Health TrialsbyHealthPanel

Registry and Monitoring of ImmuNe-mediated Inflammatory Diseases

ConditionImmuNe-Mediated Inflammatory Diseases
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorI.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

About this trial

Formation of a registry of IMID patients to assess the evolution of resistance to conventional and target therapies. This aim is achieved by evaluating the achievement of PASI 50 and PASI 75 scores at week 16 from the start of treatment.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with a diagnosis of IMID.

Patients of any age, including minors.

Patients treated with approved medications for the condition in question and/or phototherapy.

Patients who agree to sign informed consent.

Disqualifiers

Patients without a diagnosis of IMID.

Patients who do not consent to sign informed consent.

Trial population

In this study (registry) will be included all IMID patients afferent to the UO of Dermatology of IRCCS Istituto Ortopedico Galeazzi for an estimated total of 5 years of recruitment.

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

  • Questionnaires

    Other intervention

    This is a collection of data from normal clinical routine: patients will be asked to record the assessments they undergo during their course of treatment, without changing clinical practice in any way. Data inherent to the following procedures will be collected: examinations, laboratory tests, imaging tests, questionnaires and rating scales.

Treatment groups

2,000 Participants
are divided into 12 treatment groups

12

Treatment groups

See each treatment group below.

Group A: Psoriasis1 intervention
Group B: Psoriatic arthritis1 intervention
Group C: Atopic dermatitis1 intervention
Group D: Chronic urticaria1 intervention
Group E: Suppurative hydrosadenitis1 intervention
Group F: Systemic lupus erythematosus1 intervention
Group G: Acne vulgaris1 intervention
Group H: Rosacea1 intervention
Group I: Seborrheic dermatitis1 intervention
Group J: Contact dermatitis1 intervention
Group K: Chronic eczema of the hands1 intervention
Group L: Vitiligo1 intervention

Trial outcomes

Primary outcomes

1

Registry of ImmuNe-mediated inflammatory Diseases (IMIDs)

Formation of a registry of IMID patients to assess the evolution of resistance to conventional and target therapies.

Time frame
15 years

Secondary outcomes

1

PASI 50

Assess attainment of PASI 50 score from the start of treatment to all follow-ups

Time frame
15 years
2

PASI 75

Assess attainment of PASI 75 score from the start of treatment to all follow-ups

Time frame
15 years

Other outcomes

1

Special populations

Quantification and monitoring of IMID patients belonging to "special populations". Special populations include: homeless, transgender, amputees, para and quadriplegics.

Time frame
15 years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: